Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 1Pancreatic Adenocarcinoma 1Colonic Neoplasms 1Cholangiocarcinoma 1

Interventions

Gemcitabine 4Fluorouracil 4dehydroftorafur 3Taxes 3Oxaliplatin 3Albumin-Bound Paclitaxel 3130-nm albumin-bound paclitaxel 3Radiotherapy 2Leucovorin 2Irinotecan 2tocilizumab 1selicrelumab 1niraparib 1indusatumab 1cobimetinib 1atezolizumab 1X-Rays 1Tiragolumab 1Surgical Procedures, Operative 1Specimen Handling 1Radiotherapy, Intensity-Modulated 1Radiotherapy, Image-Guided 1Radiation 1Pancreatectomy 1PEGPH20 1Nivolumab 1Losartan 1Ipilimumab 1Folfox protocol 1Cetuximab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Pancreatic Adenocarcinoma × Pancreatectomy × Clear all
NCT02562716 2022-10-19

S1505: Combination Chemotherapy or Gemcitabine Hydrochloride and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Before Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery

SWOG Cancer Research Network

Phase 2 Completed
147 enrolled 16 charts
Gastrointestinal

Pancreatic Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡